Stay updated on Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A notice about NIH websites transitioning terminology from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page.
    Difference
    1%
    Check dated 2026-10-25T12:35:13.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T12:07:40.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1, while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T13:50:35.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content and indicating an access/permissions issue. The surrounding site chrome remains visible, showing this is an error state rather than new study information.
    Difference
    23%
    Check dated 2026-09-20T11:26:29.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing the previous v3.6.5. This reflects a minor update to the page's metadata or content, with no impact on study details.
    Difference
    0.0%
    Check dated 2026-08-29T23:47:24.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.4 to v3.6.5. This reflects a minor update to the page metadata rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-08-08T23:21:56.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page.